News
3h
TipRanks on MSNDimerix Advances with FDA Approval and New Licensing DealDimerix Limited ( ($AU:DXB) ) has provided an announcement. Dimerix Limited announced significant progress in its quarterly activities report, ...
Following a meeting with the US FDA, clinical-stage biotech Dimerix has confirmed the appropriate primary endpoint for full ...
20h
Clinical Trials Arena on MSNFDA confirms primary goal for Dimerix’s DMX-200 trial to treat FSGSThe US Food and Drug Administration (FDA) has confirmed proteinuria as an acceptable primary endpoint in Dimerix ‘s Phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results